|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.72 USD | -1.93% |
|
-6.49% | -20.07% |
| 11/06 | British device maker Halma's shares slump on slower annual growth forecast | RE |
| 11/06 | CME Group Enters Licensing Agreement With Morningstar to Offer Derivatives Products | DJ |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 169.93Cr | 187.06Cr | 203.86Cr | 227.51Cr | 244.55Cr | |||||
Total Revenues | 169.93Cr | 187.06Cr | 203.86Cr | 227.51Cr | 244.55Cr | |||||
Cost of Goods Sold, Total | 70Cr | 78Cr | 84Cr | 90Cr | 95Cr | |||||
Gross Profit | 100.09Cr | 109.13Cr | 119.51Cr | 137.94Cr | 149.26Cr | |||||
Selling General & Admin Expenses, Total | 57Cr | 72Cr | 78Cr | 77Cr | 80Cr | |||||
Depreciation & Amortization - (IS) | 15Cr | 17Cr | 18Cr | 19Cr | 19Cr | |||||
Other Operating Expenses, Total | 72Cr | 89Cr | 96Cr | 96Cr | 99Cr | |||||
Operating Income | 28Cr | 21Cr | 23Cr | 42Cr | 51Cr | |||||
Interest Expense, Total | -1.04Cr | -3.01Cr | -6.07Cr | -4.99Cr | -4Cr | |||||
Interest And Investment Income | 17L | 17L | 90L | 1.22Cr | 1.14Cr | |||||
Net Interest Expenses | -87L | -2.84Cr | -5.17Cr | -3.77Cr | -2.86Cr | |||||
Income (Loss) On Equity Invest. | 54L | -36L | -1.92Cr | -1.74Cr | -33L | |||||
Currency Exchange Gains (Loss) | -37L | -67L | 1.15Cr | -49L | - | |||||
Other Non Operating Income (Expenses) | - | - | - | - | 10L | |||||
EBT, Excl. Unusual Items | 28Cr | 17Cr | 17Cr | 36Cr | 48Cr | |||||
Restructuring Charges | - | -2.58Cr | - | - | -45L | |||||
Gain (Loss) On Sale Of Investments | 59L | -21L | 29L | 38L | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 11Cr | 2.27Cr | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | -2.7Cr | -1.16Cr | - | - | 22L | |||||
EBT, Incl. Unusual Items | 26Cr | 13Cr | 17Cr | 47Cr | 50Cr | |||||
Income Tax Expense | 6.26Cr | 5.65Cr | 3.3Cr | 10Cr | 12Cr | |||||
Earnings From Continuing Operations | 19Cr | 7.05Cr | 14Cr | 37Cr | 37Cr | |||||
Net Income to Company | 19Cr | 7.05Cr | 14Cr | 37Cr | 37Cr | |||||
Net Income - (IS) | 19Cr | 7.05Cr | 14Cr | 37Cr | 37Cr | |||||
Net Income to Common Incl Extra Items | 19Cr | 7.05Cr | 14Cr | 37Cr | 37Cr | |||||
Net Income to Common Excl. Extra Items | 19Cr | 7.05Cr | 14Cr | 37Cr | 37Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.5 | 1.65 | 3.31 | 8.64 | 8.93 | |||||
Basic EPS - Continuing Operations | 4.5 | 1.65 | 3.31 | 8.64 | 8.93 | |||||
Basic Weighted Average Shares Outstanding | 4.3Cr | 4.26Cr | 4.26Cr | 4.28Cr | 4.19Cr | |||||
Net EPS - Diluted | 4.45 | 1.64 | 3.29 | 8.58 | 8.87 | |||||
Diluted EPS - Continuing Operations | 4.45 | 1.64 | 3.29 | 8.58 | 8.87 | |||||
Diluted Weighted Average Shares Outstanding | 4.34Cr | 4.29Cr | 4.29Cr | 4.31Cr | 4.22Cr | |||||
Normalized Basic EPS | 4.03 | 2.44 | 2.51 | 5.27 | 7.09 | |||||
Normalized Diluted EPS | 3.99 | 2.43 | 2.49 | 5.23 | 7.04 | |||||
Dividend Per Share | 1.3 | 1.46 | 1.53 | 1.67 | 1.86 | |||||
Payout Ratio | 28.04 | 87.23 | 45.29 | 18.73 | 20.55 | |||||
Supplemental Items | ||||||||||
EBITDA | 37Cr | 31Cr | 33Cr | 52Cr | 59Cr | |||||
EBITA | 35Cr | 27Cr | 30Cr | 49Cr | 57Cr | |||||
EBIT | 28Cr | 21Cr | 23Cr | 42Cr | 51Cr | |||||
EBITDAR | 43Cr | 37Cr | 40Cr | 58Cr | 66Cr | |||||
Effective Tax Rate - (Ratio) | 24.46 | 44.49 | 18.95 | 21.95 | 24.51 | |||||
Current Domestic Taxes | 5.19Cr | 6.4Cr | 4.11Cr | 10Cr | 12Cr | |||||
Current Foreign Taxes | 2.3Cr | 3.01Cr | 2.43Cr | 3.43Cr | 4.54Cr | |||||
Total Current Taxes | 7.49Cr | 9.41Cr | 6.54Cr | 14Cr | 16Cr | |||||
Deferred Domestic Taxes | -31L | -2.76Cr | -1.98Cr | -2.41Cr | -3.54Cr | |||||
Deferred Foreign Taxes | -92L | -1Cr | -1.26Cr | -1.05Cr | -69L | |||||
Total Deferred Taxes | -1.23Cr | -3.76Cr | -3.24Cr | -3.46Cr | -4.23Cr | |||||
Normalized Net Income | 17Cr | 10Cr | 11Cr | 23Cr | 30Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 27Cr | 36Cr | 42Cr | 44Cr | 46Cr | |||||
General and Administrative Expenses | 23Cr | 30Cr | 29Cr | 27Cr | 33Cr | |||||
Research And Development Expense From Footnotes | 5.99Cr | 6.43Cr | 8.12Cr | 9.49Cr | 10Cr | |||||
Net Rental Expense, Total | 5.87Cr | 5.85Cr | 6.56Cr | 5.9Cr | 6.22Cr | |||||
Imputed Operating Lease Interest Expense | 84.33L | 1.52Cr | 2.57Cr | 2.28Cr | 1.84Cr | |||||
Imputed Operating Lease Depreciation | 5.03Cr | 4.33Cr | 3.99Cr | 3.62Cr | 4.38Cr | |||||
Stock-Based Comp., COGS (Total) | 1.65Cr | 2.16Cr | 2.38Cr | 2.33Cr | 2.64Cr | |||||
Stock-Based Comp., S&M Exp. (Total) | 44L | 85L | 83L | 90L | 84L | |||||
Stock-Based Comp., G&A Exp. (Total) | 2.1Cr | 5.31Cr | 2.07Cr | 2.24Cr | 2.16Cr | |||||
Total Stock-Based Compensation | 4.19Cr | 8.32Cr | 5.28Cr | 5.47Cr | 5.64Cr |
- Stock Market
- Stocks
- MORN Stock
- Financials Morningstar, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















